Timothy R Pearson's Net Worth

$917 Thousand

Estimate Recalculated Jun 24, 2024 03:34PM EST

Who is Timothy R Pearson?

Timothy R Pearson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TESARO, Inc., GLYCOMIMETICS INC, Ra Pharmaceuticals, Inc., CATALYST HEALTH SOLUTIONS, INC., and Korro Bio, Inc..

SEC CIK

Timothy R Pearson's CIK is 0001528617

Past Insider Trading and Trends

2018 was Timothy R Pearson's most active year for acquiring shares with 6 total transactions. Timothy R Pearson's most active month to acquire stocks was the month of February. 2019 was Timothy R Pearson's most active year for disposing of shares, totalling 9 transactions. Timothy R Pearson's most active month to dispose stocks was the month of December. 2022 saw Timothy R Pearson paying a total of $25,026.00 for 40,400 shares, this is the most they've acquired in one year. In 2019 Timothy R Pearson cashed out on 295,326 shares for a total of $465,825.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TESARO, Inc. No price found

Exec. VP, CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.21K
$75.00
-$465,825.00
0
Jan 22
Form 4
+112.12%
3.28K
$54.86
-$141,264.50
6.21K
Scheduled
Mar 1 - Mar 2
Form 4
∞
2.93K
$177.61
-$257,001.67
2.93K
Scheduled
Mar 1 - Mar 2
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Mar 6
Form 4
—
0
—
—
0
May 27
Form 3
—
0
—
—
0
No matching records found

GLYCOMIMETICS INC (GLYC) Snapshot price: $3.16

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 1
Form 4
—
0
—
—
0
May 19
Form 4
+369.52%
19.4K
$1.29
$25,026.00
24.65K
Nov 11
Form 4
—
0
—
—
0
May 18
Form 4
∞
5.25K
—
—
5.25K
May 18
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 25
Form 4/A
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Mar 31
Form 3
—
0
—
—
0
No matching records found

Ra Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 2
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 20
Form 3
—
0
—
—
0
No matching records found

CATALYST HEALTH SOLUTIONS, INC. No price found

EVP & Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-40.00K
—
—
0
Jul 2
Form 4
+33.33%
10K
—
—
40K
Feb 23
Form 4
∞
30K
—
—
30K
Sep 15
Form 3
—
0
—
—
0
No matching records found

Korro Bio, Inc. (KRRO) Snapshot price: $60.255

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Nov 3
Form 3
—
0
—
—
0
No matching records found